| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | 10%+ Owner | Common Stock | 4,443,122 | $58,842,042 | $13.24 | 16 Sep 2024 | By Biocon Limited |
| Bicara Therapeutics Inc. | 10%+ Owner | Common Stock | 1,080,775 | $14,313,136 | $13.24 | 16 Sep 2024 | By Biocon Pharma Inc. |
| Bicara Therapeutics Inc. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Biocon Limited | ||
| Bicara Therapeutics Inc. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Biocon Pharma Inc. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 16 Sep 2024 | 4 | $0 | 4 | 10%+ Owner | 16 Sep 2024, 16:39 |
| BCAX | Bicara Therapeutics Inc. | 12 Sep 2024 | 0 | $0 | 3 | 10%+ Owner | 12 Sep 2024, 21:00 |